JP4840594B2 - 抗不整脈薬としての3環性ベンゾピラン化合物 - Google Patents

抗不整脈薬としての3環性ベンゾピラン化合物 Download PDF

Info

Publication number
JP4840594B2
JP4840594B2 JP2006530022A JP2006530022A JP4840594B2 JP 4840594 B2 JP4840594 B2 JP 4840594B2 JP 2006530022 A JP2006530022 A JP 2006530022A JP 2006530022 A JP2006530022 A JP 2006530022A JP 4840594 B2 JP4840594 B2 JP 4840594B2
Authority
JP
Japan
Prior art keywords
group
carbon atoms
amino
optionally substituted
halogen atom
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP2006530022A
Other languages
English (en)
Japanese (ja)
Other versions
JP2007530436A (ja
JP2007530436A5 (https=
Inventor
一彦 生頼
幸宏 繁田
理 上杉
匠 岡田
智行 松田
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Nissan Chemical Corp
Original Assignee
Nissan Chemical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nissan Chemical Corp filed Critical Nissan Chemical Corp
Priority to JP2006530022A priority Critical patent/JP4840594B2/ja
Publication of JP2007530436A publication Critical patent/JP2007530436A/ja
Publication of JP2007530436A5 publication Critical patent/JP2007530436A5/ja
Application granted granted Critical
Publication of JP4840594B2 publication Critical patent/JP4840594B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D513/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D498/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D498/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D498/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D515/00Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D515/02Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen, oxygen, and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D515/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pyrane Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Dental Preparations (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2006530022A 2004-03-23 2005-03-23 抗不整脈薬としての3環性ベンゾピラン化合物 Expired - Lifetime JP4840594B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2006530022A JP4840594B2 (ja) 2004-03-23 2005-03-23 抗不整脈薬としての3環性ベンゾピラン化合物

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
JP2004084605 2004-03-23
JP2004084605 2004-03-23
JP2006530022A JP4840594B2 (ja) 2004-03-23 2005-03-23 抗不整脈薬としての3環性ベンゾピラン化合物
PCT/JP2005/006004 WO2005090357A1 (en) 2004-03-23 2005-03-23 Tricyclic benzopyran compound as anti-arrhythmic agents

Publications (3)

Publication Number Publication Date
JP2007530436A JP2007530436A (ja) 2007-11-01
JP2007530436A5 JP2007530436A5 (https=) 2008-03-21
JP4840594B2 true JP4840594B2 (ja) 2011-12-21

Family

ID=34962589

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006530022A Expired - Lifetime JP4840594B2 (ja) 2004-03-23 2005-03-23 抗不整脈薬としての3環性ベンゾピラン化合物

Country Status (30)

Country Link
US (2) US7652008B2 (https=)
EP (1) EP1732929B1 (https=)
JP (1) JP4840594B2 (https=)
KR (2) KR101085979B1 (https=)
CN (3) CN102190661B (https=)
AT (1) ATE485299T1 (https=)
AU (2) AU2005223612B2 (https=)
BR (1) BRPI0508768A (https=)
CA (1) CA2558139C (https=)
CY (1) CY1111250T1 (https=)
CZ (1) CZ2006598A3 (https=)
DE (1) DE602005024245D1 (https=)
DK (1) DK1732929T3 (https=)
EG (1) EG27163A (https=)
ES (1) ES2353021T3 (https=)
HR (1) HRP20110005T1 (https=)
IL (1) IL177950A (https=)
MX (1) MXPA06010880A (https=)
NO (1) NO339495B1 (https=)
NZ (2) NZ549570A (https=)
PL (1) PL1732929T3 (https=)
PT (1) PT1732929E (https=)
RS (1) RS51742B (https=)
RU (1) RU2380370C2 (https=)
SI (1) SI1732929T1 (https=)
SK (1) SK287994B6 (https=)
TW (1) TWI352704B (https=)
UA (1) UA91189C2 (https=)
WO (1) WO2005090357A1 (https=)
ZA (1) ZA200607388B (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2353021T3 (es) * 2004-03-23 2011-02-24 Nissan Chemical Industries, Ltd. Compuesto de benzopirano tricíclico como agentes anti-arrítmicos.
RU2448112C2 (ru) 2006-03-10 2012-04-20 Ниссан Кемикал Индастриз, Лтд. Способ получения оптически активного соединения оксида хромена
TW201022223A (en) * 2008-08-14 2010-06-16 Nissan Chemical Ind Ltd Di-substituted benzopyrane compound
KR101703202B1 (ko) * 2009-04-30 2017-02-06 닛산 가가쿠 고교 가부시키 가이샤 3환성 벤조피란 화합물의 신규한 결정형태 및 그 제조방법
US8431576B2 (en) 2009-06-25 2013-04-30 Alkermes Pharma Ireland Limited Heterocyclic compounds for the treatment of neurological and psychological disorders
JPWO2014051077A1 (ja) * 2012-09-27 2016-08-25 日産化学工業株式会社 高純度の含窒素複素環化合物の製造方法
JP6202280B2 (ja) * 2012-09-27 2017-09-27 日産化学工業株式会社 含窒素複素環n−オキシド化合物の製造方法
JPWO2015012271A1 (ja) * 2013-07-25 2017-03-02 日産化学工業株式会社 複素環化合物の製造方法
US11168094B2 (en) 2017-01-06 2021-11-09 Azcuris Co., Ltd. Quinolinone derivative and pharmaceutical composition for preventing or treating allergic diseases such as asthma or atopic dermatitis including the quinolinone derivative as active ingredient
EP3761983A1 (en) 2018-03-05 2021-01-13 Alkermes Pharma Ireland Limited Aripiprazole dosing strategy
CN108727261B (zh) * 2018-06-21 2021-09-24 济南大学 一种硝基取代喹那啶的制备方法
US20220071951A1 (en) * 2018-12-28 2022-03-10 Osaka University Therapeutic agent for inherited bradyarrhythmia
RU2754610C1 (ru) * 2020-04-14 2021-09-03 Георгий Викторович ТЕЦ Препарат для лечения заболеваний, вызванных бактериями
CN115916201B (zh) * 2020-06-26 2024-09-17 国立大学法人大阪大学 药剂诱发性心动过缓及心动过缓性心律失常治疗药

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
JPH024791A (ja) * 1988-06-23 1990-01-09 Nissan Chem Ind Ltd ピラノベンゾトリアゾール誘導体
JPH03141286A (ja) * 1989-07-17 1991-06-17 Nissan Chem Ind Ltd 光学活性ピラノベンゾオキサジアゾール誘導体
JPH04290876A (ja) * 1990-11-26 1992-10-15 E R Squibb & Sons Inc ベンゾジアゾロ類似体
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZM7682A1 (en) 1981-09-25 1983-05-23 Beecham Group Plc Active compounds
JPS5867683U (ja) 1981-10-28 1983-05-09 株式会社ナムコ 歩行ロボツト
US5097037A (en) * 1989-07-17 1992-03-17 Nissan Chemical Industries, Ltd. Process for the optical resolution of pyranobenzoxadiazole compounds
UA27973C2 (uk) * 1993-04-02 2000-10-16 Ніссан Кемікал Індастріз Лтд Лікарський засіб для лікування серцевої недостатності
JP2734457B2 (ja) 1994-02-23 1998-03-30 日産化学工業株式会社 不斉エポキシ化反応
WO1995034547A1 (en) * 1994-06-10 1995-12-21 Smithkline Beecham Plc C-4 amide substituted compounds and their use as therapeutic agents
HRP970255B1 (en) * 1996-05-15 2003-10-31 Hoechst Ag Sulfonamido substituted chromane derivatives, method for their preparation, their use as medicaments or diagnostic agents as well as medicaments containing them
US6486178B1 (en) 1998-06-03 2002-11-26 Nissan Chemical Industries, Ltd. Indane derivatives
AU5444499A (en) 1998-09-01 2000-03-21 Nissan Chemical Industries Ltd. Benzoxazine derivatives
AU2830800A (en) 1999-03-25 2000-10-16 Nissan Chemical Industries Ltd. Chroman derivatives
CA2383583C (en) * 1999-09-17 2009-04-07 Nissan Chemical Industries, Ltd. Benzopyran derivative
EP1214307B1 (en) 1999-09-24 2004-04-07 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
US6677371B1 (en) 1999-10-05 2004-01-13 Nissan Chemical Industries, Ltd. 4-oxybenzopyran derivative
TW589305B (en) 2001-02-14 2004-06-01 Nissan Chemical Ind Ltd 4-aminobenzopyran derivatives
EP1401823B1 (en) 2001-06-25 2005-10-05 Nissan Chemical Industries, Ltd. Substituted benzopyran derivatives against arrhythmia
WO2003014113A1 (en) 2001-08-06 2003-02-20 Glenmark Pharmaceuticals Limited Novel benzopyran compounds and process for their preparation and use
ES2353021T3 (es) * 2004-03-23 2011-02-24 Nissan Chemical Industries, Ltd. Compuesto de benzopirano tricíclico como agentes anti-arrítmicos.

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0327127A1 (en) * 1988-02-03 1989-08-09 Nissan Chemical Industries Ltd. Pyranobenzoxadiazole derivatives, preparation, use and compositions comprising them
JPH024791A (ja) * 1988-06-23 1990-01-09 Nissan Chem Ind Ltd ピラノベンゾトリアゾール誘導体
JPH03141286A (ja) * 1989-07-17 1991-06-17 Nissan Chem Ind Ltd 光学活性ピラノベンゾオキサジアゾール誘導体
JPH04290876A (ja) * 1990-11-26 1992-10-15 E R Squibb & Sons Inc ベンゾジアゾロ類似体
JPH07300414A (ja) * 1993-04-02 1995-11-14 Nissan Chem Ind Ltd 心不全治療薬

Also Published As

Publication number Publication date
NZ549570A (en) 2010-08-27
TW200600509A (en) 2006-01-01
RU2380370C2 (ru) 2010-01-27
IL177950A (en) 2013-04-30
ES2353021T3 (es) 2011-02-24
EP1732929A1 (en) 2006-12-20
AU2005223612A1 (en) 2005-09-29
CA2558139A1 (en) 2005-09-29
ZA200607388B (en) 2008-07-30
AU2010202900A1 (en) 2010-07-29
AU2010202900B2 (en) 2011-10-27
RU2006137284A (ru) 2008-04-27
JP2007530436A (ja) 2007-11-01
NO339495B1 (no) 2016-12-19
KR101085979B1 (ko) 2011-11-22
RS51742B (sr) 2011-10-31
PL1732929T3 (pl) 2011-04-29
US20100069374A1 (en) 2010-03-18
MXPA06010880A (es) 2006-12-15
CN1934116A (zh) 2007-03-21
CY1111250T1 (el) 2015-06-11
WO2005090357A1 (en) 2005-09-29
CN101429200B (zh) 2012-05-30
AU2005223612B2 (en) 2010-06-24
HK1099299A1 (en) 2007-08-10
PT1732929E (pt) 2010-12-21
CA2558139C (en) 2012-01-17
KR101019402B1 (ko) 2011-03-07
KR20100130249A (ko) 2010-12-10
SK50792006A3 (sk) 2007-09-06
US20080004262A1 (en) 2008-01-03
IL177950A0 (en) 2006-12-31
SK287994B6 (sk) 2012-09-03
US7652008B2 (en) 2010-01-26
UA91189C2 (en) 2010-07-12
DE602005024245D1 (de) 2010-12-02
ATE485299T1 (de) 2010-11-15
KR20070009638A (ko) 2007-01-18
NO20064819L (no) 2006-10-23
CN101429200A (zh) 2009-05-13
HRP20110005T1 (hr) 2011-02-28
DK1732929T3 (da) 2010-12-20
TWI352704B (en) 2011-11-21
SI1732929T1 (sl) 2010-12-31
US7964623B2 (en) 2011-06-21
NZ585606A (en) 2011-11-25
EG27163A (en) 2015-08-24
EP1732929B1 (en) 2010-10-20
CN102190661A (zh) 2011-09-21
CN1934116B (zh) 2012-10-10
BRPI0508768A (pt) 2007-02-27
CN102190661B (zh) 2013-07-31
CZ2006598A3 (cs) 2006-11-15

Similar Documents

Publication Publication Date Title
US7964623B2 (en) Tricyclic benzopyrane compound
AU2005214276B2 (en) Benzopyran compounds useful for the treatment of arrhythmia
HK1099299B (en) Tricyclic benzopyran compound as anti-arrhythmic agents
JP2010065029A (ja) 複素環ピラン化合物

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20080124

A524 Written submission of copy of amendment under article 19 pct

Free format text: JAPANESE INTERMEDIATE CODE: A524

Effective date: 20080124

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20080124

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110316

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110512

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110907

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110920

R151 Written notification of patent or utility model registration

Ref document number: 4840594

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R151

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20141014

Year of fee payment: 3

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

S533 Written request for registration of change of name

Free format text: JAPANESE INTERMEDIATE CODE: R313533

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

EXPY Cancellation because of completion of term